Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/14119| Title: | Evidence-based drug therapy in the management of heart failure |
| Authors: | Gauci, Marise |
| Keywords: | Heart failure -- Chemotherapy Heart failure -- Treatment Evidence-based medicine Adrenergic beta blockers |
| Issue Date: | 2011 |
| Publisher: | Malta College of Pharmacy Practice |
| Citation: | Gauci, M. (2011). Evidence-based drug therapy in the management of heart failure. Journal of the Malta College of Pharmacy Practice, 17, 5-10. |
| Abstract: | This article provides an update on the drug treatment for heart failure (HF) mostly based on the recent clinical guidelines issued by the National Institute of Clinical Excellence (NICE).1 New high quality evidence from randomised controlled trials has resulted in greater value being given to the use of beta-blockers (BBs) and to the use of the hydralazine-nitrate combination. The importance of monitoring laboratory and clinical parameters to ensure safe and effective drug treatment is also highlighted. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/14119 |
| Appears in Collections: | JMCPP, Issue 17 JMCPP, Issue 17 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2011-17-1.pdf | Evidence-based drug therapy in the management of heart failure | 76.47 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.